Last reviewed: June 25, 2026
Last updated: June 25, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Losing weight with medication support has transformed for millions of adults, yet most people receive the same standardized dose regardless of their unique biology. PlexusDx takes a precision approach, matching you with compounded GLP-1 options and optional genetic insights to guide which medication and strength may work best for your weight loss goals.
Understanding GLP-1 Weight Loss Medications and Your Options
GLP-1 receptor agonists work by slowing stomach emptying, increasing fullness signals to the brain, and reducing hunger hormones—three mechanisms that together help control appetite and food intake. Semaglutide and tirzepatide are the two primary active compounds in compounded weight loss therapy; tirzepatide also activates GIP receptors, adding a fourth pathway that may amplify results for certain patients. PlexusDx compounds both medications in injectable and oral forms, giving you flexibility to choose the delivery method that fits your lifestyle and comfort level.
Many people entering weight loss treatment worry about finding an affordable option without insurance or long-term membership fees. PlexusDx eliminates those barriers by offering compounded medications from licensed 503A pharmacies at flat monthly prices, with no flat per-compound pricing changes—your dose may need to go up, but your price won't. All treatments are HSA and FSA eligible, and service is available across all 50 states, making precision weight loss accessible regardless of your location or insurance status.
How Genetic Testing Shapes Your Personalized Treatment Plan
Not every GLP-1 medication works equally well for every person, because genetic variation in key peptide pathways influences how your body responds to these drugs. The Precision Peptide Genetic Test from PlexusDx examines variants in four critical genes—GIPR, GLP1R, FTO, and MC4R—plus 49 other peptides across 14 metabolic pathways to predict which compound and strength may deliver the best results for your specific biology. This test is available as a $99 add-on after your first month of treatment, allowing you to start therapy immediately while gaining insights for long-term optimization.
By identifying whether your genetics favor semaglutide, tirzepatide, or a dual-compound approach, the Precision Peptide test helps reduce trial-and-error and accelerates your path to effective dosing. The test maps over 150 genetic insights related to appetite regulation, fat storage, insulin sensitivity, and satiety—factors that directly influence how quickly you'll see results and which side effects you're more likely to experience. Armed with this genetic roadmap, PlexusDx providers can confidently recommend whether you should start with compounded semaglutide at $149/month or explore tirzepatide injections starting at $249/month.
Comparing Semaglutide, Tirzepatide, and Dual-Compound Protocols
Semaglutide is a single-receptor agonist that activates GLP-1 pathways to reduce appetite and improve blood sugar control; injected semaglutide from PlexusDx starts at $149/month, while oral semaglutide begins at $249/month. Tirzepatide is a dual-receptor agonist that activates both GLP-1 and GIP pathways, potentially offering stronger weight loss effects in clinical studies; compounded tirzepatide injections start at $249/month, and the oral form starts at $279/month. For patients whose genetic profile suggests they may benefit from maximal receptor activation, PlexusDx offers GLP-Squared—a proprietary dual-compound injection combining both semaglutide and tirzepatide—starting at $249/month, or GLP-Squared oral at $369/month.
The choice between these options depends on your weight loss goals, injection comfort level, genetic predispositions revealed by the Precision Peptide test, and medical history. Patients with stronger FTO gene variants linked to appetite dysregulation may respond better to tirzepatide's dual-pathway action, while those with specific GLP1R mutations might achieve excellent results with semaglutide alone. Oral medications offer convenience for needle-averse patients, though injectable forms typically provide faster absorption and more predictable dosing—a factor the Precision Peptide test can help clarify for your individual case.
Starting Your Personalized Weight Loss Plan at PlexusDx
Beginning treatment with PlexusDx is straightforward: complete a brief online assessment, consult with a licensed provider to confirm suitability, and receive your first shipment of compounded medication from a licensed 503A pharmacy within days. You'll choose between injected or oral semaglutide, tirzepatide, or a dual-compound option based on your preferences and medical history; pricing is flat at the tier you select, with no additional charges as your strength increases. If you're interested in genetic guidance, you can add the Precision Peptide test for $99 after one month of treatment, using early clinical response to inform whether genetic insights might refine your long-term protocol.
PlexusDx providers monitor your progress monthly, adjusting your dose when needed to maximize safety and results while keeping your monthly cost stable. The combination of compounded medication access, no membership or insurance requirement, HSA/FSA eligibility, and optional precision genetic testing creates a weight loss pathway designed for real people with real constraints. Whether you start with the affordable Microdose GLP-1 Protocol at $129/month or move directly to a full-strength injectable protocol, PlexusDx structures pricing and clinical support to remove barriers between you and sustainable weight loss.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Precision Peptide Genetic Test starts at $99 add-on. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
Is compounded semaglutide the same as brand-name Ozempic?
Compounded semaglutide contains the same active ingredient as Ozempic but is made by licensed 503A pharmacies rather than manufactured by a pharmaceutical company. PlexusDx medications are compounded to pharmaceutical standards and start at $149/month, offering significant cost savings compared to brand-name options while maintaining quality and safety.
How much weight do people typically lose with GLP-1 therapy?
Clinical trials show semaglutide users lose 10–15% of body weight over 68 weeks, while tirzepatide users lose 15–22% across similar timeframes. Individual results vary based on genetics, diet, exercise, and starting weight; the Precision Peptide Genetic Test helps predict your likely response pattern and optimal compound choice.
Can I use my HSA or FSA to pay for PlexusDx medications?
Yes, all PlexusDx compounded medications and the Precision Peptide Genetic Test are HSA and FSA eligible. This reduces your out-of-pocket cost significantly and allows you to use pre-tax healthcare dollars toward your weight loss treatment.
What side effects should I expect from GLP-1 therapy?
Common side effects include mild nausea, vomiting, constipation, or reduced appetite—most mild and temporary during the first 1–2 weeks. Serious side effects are rare; the Precision Peptide Genetic Test can identify genetic factors that predict your side effect risk profile, helping providers tailor your starting dose and escalation plan for maximum comfort.
How does the Precision Peptide Genetic Test help choose between semaglutide and tirzepatide?
The test analyzes 49 peptides across 14 pathways, including GIPR, GLP1R, FTO, and MC4R variants that predict whether you'll respond better to single-receptor (semaglutide) or dual-receptor (tirzepatide) activation. Based on your genetic profile, PlexusDx providers recommend the compound most likely to deliver strong results with fewer side effects, starting at $99 add-on after your first month.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Is It Okay to Take Zepbound a Day Late?
Understanding the Side Effects of Wegovy for Weight Loss